Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis

Journal of Hepatology

Volumn 51, Issue 4, 2009, Pages 778-786

  Miele, Luca ^a   Vallone, Selenia ^a   Cefalo, Consuelo ^a   La Torre, Giuseppe ^b   Di Stasi, Carmine ^a   Vecchio, Fabio M ^a   D'Agostino, Magda ^a   Gabrieli, Maria L ^a   Vero, Vittoria ^a   Biolato, Marco ^a   Pompili, Maurizio ^a   Gasbarrini, Giovanni ^a   Rapaccini, Gianludovico ^a   Amerio, Pierluigi ^a   De Simone, Clara ^a   Grieco, Antonio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Fibrosis; Liver function test; Methotrexate; NAFLD; Psoriatic arthritis; Steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; METHOTREXATE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; ECHOGRAPHY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; ITALY; LABORATORY DIAGNOSIS; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; SCORING SYSTEM; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, PSORIATIC; CASE-CONTROL STUDIES; CHRONIC DISEASE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; ITALY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PSORIASIS; YOUNG ADULT;

EID: 69949187972     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.06.008     Document Type: Article

References (34)

1. Griffiths C.E., and Barker J.N. Pathogenesis and clinical features of psoriasis. Lancet 370 (2007) 263-271
2. Henseler T., and Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 32 (1995) 982-986
3. Neimann A.L., Shin D.B., Wang X., Margolis D.J., Troxel A.B., and Gelfand J.M. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55 (2006) 829-835
4. Gelfand J.M., Neimann A.L., Shin D.B., Wang X., Margolis D.J., and Troxel A.B. Risk of myocardial infarction in patients with psoriasis. JAMA 296 (2006) 1735-1741
5. Gisondi P., Tessari G., Conti A., Piaserico S., Schianchi S., Peserico A., et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 157 (2007) 68-73
6. Lonardo A., Loria P., and Carulli N. Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI.ST.E.N.A. study. Dig Liver Dis 33 (2001) 86-87
7. Lindegård B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 172 (1986) 298-304
8. Von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., and Vandenbroucke J.P. STROBE initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370 (2007) 1453-1457
9. Moll J.M.H., and Wright V. Psoriatic arthritis. Semin Arthritis Rheum 3 (1973) 55-78
10. Fredriksson T., and Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 157 (1978) 238-244
11. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
12. Angulo P., Hui J.M., Marchesini G., Bugianesi E., George J., Farrell G.C., et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45 (2007) 846-854
13. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
14. Report of the expert committee on the diagnosis and classification of diabetes mellitus diabetes care 1997; 20:1183-97.
15. Sanyal A.J. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123 (2002) 1705-1725
16. Nyfors A., and Poulsen H. Liver biopsies from psoriatics related to methotrexate therapy: two findings before and after methotrexate therapy in 88 patients. A blind study. Acta Pathol Microbiol Scand A 84 (1976) 262-270
17. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
18. Bellentani S., Saccoccio G., Masutti F., Crocè L.S., Brandi G., Sasso F., et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132 (2000) 112-117
19. Abdelmalek M.F., Liu C., Shuster J., Nelson D.R., and Asal N.R. Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 4 (2006) 1162-1169
20. Balding J., Kane D., Livingstone W., Mynett-Johnson L., Bresnihan B., Smith O., et al. Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthritis Rheum 48 (2003) 1408-1413
21. Fraser A., Fearon U., Billinghurst R.C., Ionescu M., Reece R., Barwick T., et al. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Arthritis Rheum 48 (2003) 3085-3095
22. Ritchlin C., Haas-Smith S.A., Hicks D., Cappuccio J., Osterland C.K., and Looney R.J. Patterns of cytokine production in psoriatic synovium. J Rheumatol 25 (1998) 1544-1552
23. Xu H., Uysal K.T., Becherer J.D., Arner P., and Hotamisligil G.S. Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity. Diabetes 51 (2002) 1876-1883
24. Feldstein A.E., Werneburg N.W., Canbay A., Guicciardi M.E., Bronk S.F., Rydzewski R., et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40 (2004) 185-194
25. Crespo J., Cayón A., Fernández-Gil P., Hernández-Guerra M., Mayorga M., Domi{dotless}́nguez-Di{dotless}́ez A., et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 34 (2001) 1158-1163
26. Carter-Kent C., Zein N.N., and Feldstein A.E. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am J Gastroenterol 103 (2008) 1036-1042
27. Angulo P., Keach J.C., Batts K.P., and Lindor K.D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30 (1999) 1356-1362
28. Coulson I.H., McKenzie J., Neild V.S., Joseph A.E., and Marsden R.A. A comparison of liver ultrasound with liver biopsy histology in psoriatics receiving long-term methotrexate therapy. Br J Dermatol 116 (1987) 491-495
29. Whiting-O'Keefe Q.E., Fye K.H., and Sack K.D. Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am J Med 90 (1991) 711-716
30. Ryan G.J., Barry J., Bourke J., and Phelan M. Methotrexate monitoring: a countrywide analysis of monitoring policies among dermatologists and rheumatologists in the republic of Ireland. Rheumatology 43 (2004) ii50
31. Roenigk Jr. H.H., Auerbach R., Maibach H., Weinstein G., and Lebwohl M. Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol 38 (1998) 478-485
32. Rosenberg P., Urwitz H., Johannesson A., Ros A.M., Lindholm J., Kinnman N., et al. Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment. J Hepatol 46 (2007) 1111-1118
33. Baker H. Psoriasis - clinical features. Br Med J 3 (1971) 231-233
34. Bedogni G., Miglioli L., Masutti F., Tiribelli C., Marchesini G., and Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42 (2005) 44-52